Dual Therapeutics, LLC is an oncology company that develops therapeutics for prostate cancer, lung cancer, and acute lymphoblastic leukemia. It develops oral small molecules that directly activate protein phosphatase 2, a serine/threonine phosphatase that is a tumor suppressor to disrupt multiple cancer pathways simultaneously.